Healthy volunteer safety data reported from phase IIb study of EB-01 in allergic contact dermatitis Dec. 4, 2019
Vivace Therapeutics patents transcriptional coactivator YAP1/TEAD interaction inhibitors Dec. 4, 2019
RSS